Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
The strongest online claims often leave out the most important limitations
Wegovy is specifically approved for weight management in non-diabetic people with obesity or overweight plus health complications
Treatment-Related Dysgeusia in Head and Neck Cancer Patients
Clinical Perspective: Constipation should not be an acceptable tax for taking metabolic medications
Moreover, independent blood pressure reduction and plasma lipid modulation further contribute to cardiovascular protection [58,59]